Quanbo Zhou

7PUBLICATIONS
29CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2025
CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancer.

Xiaowei He, Ji Liu, Yifan Zhou

|Aug 09, 2024
KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progression.

Zilan Xu, Yifan Zhou, Shaoqiu Liu

|Dec 22, 2023
Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma.

Bin Zhang, Xiaofeng Guo, Leyi Huang

|Oct 10, 2023
CSTF2 mediated mRNA N<sup>6</sup>-methyladenosine modification drives pancreatic ductal adenocarcinoma m<sup>6</sup>A subtypes.

Yanfen Zheng, Xingyang Li, Shuang Deng

|Sep 19, 2023
LncRNA BCAN-AS1 stabilizes c-Myc via N<sup>6</sup>-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.

Guandi Wu, Jiachun Su, Lingxing Zeng

|Jun 16, 2023
N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer.

Jiachun Su, Rui Li, Ziming Chen

Pageof 2

Frequent Collaborators

5 joint publications

Jialiang Zhang

5 joint publications

Jian Zheng

5 joint publications

Lingxing Zeng

4 joint publications

Xudong Huang